EUVIMEDEUVIMED entdecken
LeitlinieOpen Access

Treatment Guidance for Palmoplantar Pustulosis 2022

Japanese Dermatological Association Palmoplantar Pustulosis Treatment Guidance Drafting Committee, Tadashi Terui, Satomi Kobayashi iD, Toshiyuki Yamamoto iD, Yukari Okubo iD, Namiko Abe iD, Natsumi Ikumi iD, Madoka Ishii, Akiko Ito iD, Yoshinori Umezawa, Takuro Kanekura, Hiroshi Kawakami und 17 weitere

The Journal of Dermatology · 2026-07 · 53 (7)

DOI: 10.1111/1346-8138.70246 ↗

Kurz gefasst

Leitlinie in der Zeitschrift The Journal of Dermatology, online erschienen am 07.06.2026. Verfasst von Japanese Dermatological Association Palmoplantar Pustulosis Treatment Guidance Drafting Committee und 28 weiteren Autor:innen. Beteiligte Einrichtung: Division of Dermatological Science, Department of Dermatology, Nihon University School of Medicine, Tokyo, Japan. Hauptthemen laut MEDLINE: Psoriasis. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 379 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Palmoplantar pustulosis (PPP) is an inflammatory skin disease characterized by chronic and relapsing eruptions of multiple sterile pustules on the palms and soles, which subsequently crust and desquamate. In addition to pustules, vesicles and pustulo‐vesicles are often observed simultaneously. It is more prevalent among Japanese individuals, and the number of affected patients in Japan is estimated to be approximately 140,000 based on national health insurance claims data in Japan. Sterile osteitis occurs in 10%–30% of patients with PPP or a history of PPP, a condition referred to as pustulotic arthro‐osteitis. Because it has become evident that focal infections act as triggering factors in approximately 80% of both conditions, their therapeutic algorithms differ fundamentally from those for psoriasis. The aim of the Treatment Guidance for Palmoplantar Pustulosis 2022 was to clarify the clinical manifestations and histopathological findings supporting the diagnosis of PPP, and to explain treatment algorithms and recommendation grades based on differences in triggering factors and pathophysiology between PPP and psoriasis. Although the level of evidence is limited due to the ethical and practical difficulties in conducting rigorous double‐blinde clinical trials to evaluate the efficacy of focal infection treatment, the treatment recommendations were determined through expert consensus based on extensive clinical experience accumulated in Japan, together with relevant basic research findings.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PsoriasisHumansAlgorithmsJapanOsteitisPractice Guidelines as TopicSkin

Stichwörter der Autor:innen

diagnosisepidemiologyguidelinepalmoplantar pustulosispustulotic arthro‐osteitis

Autor:innen und Institutionen

  • Division of Dermatological Science, Department of Dermatology, Nihon University School of Medicine, Tokyo, Japan.
  • Department of Dermatology, Seibo International Catholic Hospital, Tokyo, Japan.
  • Department of Dermatology, Tokyo Women's Medical University, Tokyo, Japan.
  • Department of Dermatology, Fukushima Medical University, Fukushima, Japan.
  • Department of Dermatology, Tokyo Medical University, Tokyo, Japan.
  • Division of Dermatology, Nagata Clinic, Niigata, Japan.

ORCID-Profile: Satomi Kobayashi, Toshiyuki Yamamoto, Yukari Okubo, Namiko Abe, Natsumi Ikumi, Akiko Ito, Mari Kishibe, Motoki Nakamura, Koremasa Hayama, Yuka Matsumoto, Akimichi Morita

Zitieren

APA

Japanese Dermatological Association Palmoplantar Pustulosis Treatment Guidance Drafting Committee, Terui, T., Kobayashi, S., Yamamoto, T., Okubo, Y., Abe, N., Ikumi, N., Ishii, M., Ito, A., Umezawa, Y., Kanekura, T., Kawakami, H., Kishibe, M., Kuroki, K., Kurumatani, A., Kouno, M., Shimizu, T., Tsuji, S., Toichi, E., …, & Murakami, M. (2026). Treatment Guidance for Palmoplantar Pustulosis 2022. The Journal of Dermatology, 53(7). https://doi.org/10.1111/1346-8138.70246

Vancouver

Japanese Dermatological Association Palmoplantar Pustulosis Treatment Guidance Drafting Committee, Terui T, Kobayashi S, Yamamoto T, Okubo Y, Abe N, et al. Treatment Guidance for Palmoplantar Pustulosis 2022. The Journal of Dermatology. 2026;53(7). doi:10.1111/1346-8138.70246

BibTeX
@article{JapaneseDermatologicalAssociationPalmoplantarPustulosisTreatmentGuidanceDraftingCommittee2026,
  author = {Japanese Dermatological Association Palmoplantar Pustulosis Treatment Guidance Drafting Committee, Japanese Dermatological Association Palmoplantar Pustulosis Treatment Guidance Drafting Committee and Terui, Tadashi and Kobayashi, Satomi and Yamamoto, Toshiyuki and Okubo, Yukari and Abe, Namiko and Ikumi, Natsumi and Ishii, Madoka and Ito, Akiko and Umezawa, Yoshinori and Kanekura, Takuro and Kawakami, Hiroshi and Kishibe, Mari and Kuroki, Kana and Kurumatani, Ayano and Kouno, Michiyoshi and Shimizu, Tadamichi and Tsuji, Shigeyoshi and Toichi, Eiko and Nakamura, Motoki and Nishida, Emi and Hayama, Koremasa and Hirano, Hirofumi and Fujisawa, Daisuke and Fujishiro, Kanzan and Fujita, Hideki and Matsumoto, Yuka and Morita, Akimichi and Murakami, Masamoto},
  title = {Treatment Guidance for Palmoplantar Pustulosis 2022},
  journal = {The Journal of Dermatology},
  year = {2026},
  volume = {53},
  number = {7},
  doi = {10.1111/1346-8138.70246}
}
Kostenlos starten →